Cita de james971 en 10/09/2026, 04:14Triclabendazole is considered the treatment of choice for human fascioliasis, a liver fluke infection caused mainly by Fasciola hepatica and Fasciola gigantica. It is particularly effective because it works against both immature flukes migrating through the liver and mature parasites located in the bile ducts. The World Health Organization (WHO) recommends triclabendazole for treating fascioliasis. Buy Triclabendazole Online at top pharmacy Medzsupplier.
High Effectiveness Against Liver Flukes
Clinical evidence shows that triclabendazole has a high cure rate in people with fascioliasis. Published studies have reported cure rates ranging from approximately 70% to 100%, depending on the dose, infection stage, and study population. Other clinical assessments report cure rates of about 75%–95% with appropriate treatment.
One important advantage is its activity against different stages of the parasite. Many antiparasitic medicines have limited activity against immature Fasciola, whereas triclabendazole can target both immature and adult forms. This makes it useful during different phases of infection.
Recommended Treatment
WHO recommends 10 mg/kg as a single oral dose for fascioliasis. In cases where treatment failure occurs, WHO guidance allows an increased total dose of 20 mg/kg divided into two doses 12–24 hours apart. In the United States, the CDC recommends two 10 mg/kg doses given 12 hours apart for eligible patients.
Safety and Considerations
Triclabendazole is generally well tolerated, although temporary abdominal pain, nausea, vomiting, diarrhea, or other symptoms can occur after treatment. These reactions may partly result from the dying or expelled parasites.
Treatment failures have been reported, and resistance is a recognized concern. Therefore, diagnosis and treatment should be guided by a qualified healthcare professional. Follow-up testing may be necessary to confirm that the infection has cleared.
Overall, triclabendazole is highly effective against human liver fluke infections and remains the preferred medicine for fascioliasis.
Triclabendazole is considered the treatment of choice for human fascioliasis, a liver fluke infection caused mainly by Fasciola hepatica and Fasciola gigantica. It is particularly effective because it works against both immature flukes migrating through the liver and mature parasites located in the bile ducts. The World Health Organization (WHO) recommends triclabendazole for treating fascioliasis. Buy Triclabendazole Online at top pharmacy Medzsupplier.
High Effectiveness Against Liver Flukes
Clinical evidence shows that triclabendazole has a high cure rate in people with fascioliasis. Published studies have reported cure rates ranging from approximately 70% to 100%, depending on the dose, infection stage, and study population. Other clinical assessments report cure rates of about 75%–95% with appropriate treatment.
One important advantage is its activity against different stages of the parasite. Many antiparasitic medicines have limited activity against immature Fasciola, whereas triclabendazole can target both immature and adult forms. This makes it useful during different phases of infection.
Recommended Treatment
WHO recommends 10 mg/kg as a single oral dose for fascioliasis. In cases where treatment failure occurs, WHO guidance allows an increased total dose of 20 mg/kg divided into two doses 12–24 hours apart. In the United States, the CDC recommends two 10 mg/kg doses given 12 hours apart for eligible patients.
Safety and Considerations
Triclabendazole is generally well tolerated, although temporary abdominal pain, nausea, vomiting, diarrhea, or other symptoms can occur after treatment. These reactions may partly result from the dying or expelled parasites.
Treatment failures have been reported, and resistance is a recognized concern. Therefore, diagnosis and treatment should be guided by a qualified healthcare professional. Follow-up testing may be necessary to confirm that the infection has cleared.
Overall, triclabendazole is highly effective against human liver fluke infections and remains the preferred medicine for fascioliasis.